SCHRODER VENTURE MANAGERS INC.Joint Filing Agreement • March 29th, 2005 • Schroder Venture Managers LTD • Pharmaceutical preparations
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or its knows or has reason to believe that such information is inaccurate.
Microcide Pharmaceuticals, Inc. __________________________________ __________________________________ Attention:________________________ Ladies and Gentlemen: Microcide Pharmaceuticals, Inc., a Delaware corporation, (the "Company"), and ____________...Lock-Up Agreement • November 5th, 2001 • Schroder Venture Managers LTD • Pharmaceutical preparations
Microcide Pharmaceuticals, Inc., a Delaware corporation, (the "Company"), and ____________ (the "Investor"), have entered into a Subscription Agreement dated as of _________ __, 2001 (the "Subscription Agreement"), providing for the purchase of _______ shares (the "Shares") of the Company's Series B Convertible Redeemable Preferred Stock ("Company Preferred Stock") by the Investor (the "Investment").
Exhibit 3 --------- Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of...Schedule 13d Agreement • November 5th, 2001 • Schroder Venture Managers LTD • Pharmaceutical preparations
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of Microcide Pharmaceuticals, Inc.
SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP2Exhibit Agreement • April 29th, 2003 • Schroder Venture Managers LTD • Pharmaceutical preparations
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of Essential Therapeutics, Inc.
AGREEMENTVoting Agreement • April 29th, 2003 • Schroder Venture Managers LTD • Pharmaceutical preparations • Delaware
